The global market size for Glycomics/Glycobiology was USD 2.26 billion in 2022, with a projected CAGR of 13% during the forecast period. The increasing prevalence of chronic diseases, rising R&D expenditure in the field of glycomics, and the need for personalized treatment are the key drivers of market growth.

Glycomics or glycobiology is the study of saccharides, which are widely distributed in nature and play a key role in numerous biological processes. Glycobiology has a wide range of applications, including diagnostics, oncology, drug discovery and development, immunology, and others.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/3986

The rising prevalence of chronic diseases such as cancer, diabetes, and CVDs has increased interest in the study of carbohydrates and their roles in disease genesis and progression, which is another factor driving market revenue growth. Understanding the role of glycans in disease onset and progression could lead to the creation of new therapeutic targets and customized treatment.

Moreover, increasing R&D expenditure in the glycomics sector is also expected to drive revenue growth. Pharmaceutical and biotech businesses are making significant investments in glycomics R&D to create new medications and treatments. Rising accessibility of cutting-edge technologies such as mass spectrometry and NMR spectroscopy has allowed researchers to comprehend the structure and function of glycans at the molecular level, thus enabling identification of new therapeutic targets and the creation of novel medications.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/3986

The global glycomics/glycobiology market report features several prominent companies, including Agilent Technologies, Bruker Corporation, Danaher Corporation, New England Biolabs, Shimadzu Corporation, Thermo Fisher Scientific, Waters Corporation, and Zymo Research Corporation.

Furthermore, increasing government funding and initiatives are expected to drive market revenue growth. Governments from all around the world are spending money on glycomics R&D to combat various health issues such as cancer and infectious diseases. However, high instrument and equipment costs, shortage of skilled workers, and complexity of glycan research could restrain market revenue growth.

The global glycomics/glycobiology market is segmented by technology, application, end-use, and region. The market is driven by factors such as increasing research funding for glycobiology research, rising prevalence of cancer and other chronic diseases, demand for personalized medicine, and increasing technological advancements in glycobiology. The product types in the market include enzymes, instruments, kits, reagents, and others. Enzymes accounted for the largest revenue share in 2022, while the instruments segment is expected to register steady revenue growth rate during the forecast period. The kits segment is expected to account for a significantly large revenue share in the global glycomics/glycobiology market during the forecast period.

In conclusion, the glycomics/glycobiology market is expected to experience rapid revenue growth during the forecast period, driven by factors such as increasing prevalence of chronic diseases, rising R&D expenditure, and increasing government funding and initiatives. However, market growth may be restrained by high equipment costs, shortage of skilled workers, and complexity of glycan research.

Request customization of the report @

https://www.reportsanddata.com/request-customization-form/3986

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs